U.S. Std Diagnostics Market Size & Outlook, 2023-2030
U.S. std diagnostics market, 2017-2030 (US$M)
Related Markets
U.S. std diagnostics market highlights
- The U.S. std diagnostics market generated a revenue of USD 3,260.9 million in 2023 and is expected to reach USD 5,087.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, consumables (reagents and kits) was the largest revenue generating product in 2023.
- Consumables (Reagents and kits) is the most lucrative product segment registering the fastest growth during the forecast period.
Std diagnostics market data book summary
| Market revenue in 2023 | USD 3,260.9 million |
| Market revenue in 2030 | USD 5,087.9 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Consumables (reagents and kits) |
| Fastest growing segment | Consumables (Reagents and kits) |
| Historical data | 2017 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments & Services, Consumables (Reagents and kits), Softwares |
| Key market players worldwide | BD, Roche, Hologic Inc, Abbott Laboratories, Danaher Corp, Qiagen NV, OraSure Technologies Inc, Bio-Rad Laboratories Inc, BioMerieux SA, Thermo Fisher Scientific Inc, Seegene, Diasorin SpA |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.9% of the global std diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. std diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 743.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
STD Diagnostics Market Scope
STD Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. std diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to std diagnostics market will help companies and investors design strategic landscapes.
Consumables (reagents and kits) was the largest segment with a revenue share of 69.9% in 2023. Horizon Databook has segmented the U.S. std diagnostics market based on instruments & services, consumables (reagents and kits), softwares covering the revenue growth of each sub-segment from 2017 to 2030.
The U.S. held the largest share of North America STD diagnostics market in 2020. This growth can be attributed to high disposable income, rise in consumer awareness, and increase in disease burden of STDs.
The reimbursement structure associated with the use of STD diagnostics is expected to drive market growth in the U.S. UnitedHealthcare reimbursement policies may use CMS and Current Procedural Terminology (CPT) or other coding guidelines.
For molecular diagnostic tests, molecular pathology or MoPath codes provide guidance & framework to payers, such as private insurance companies & Medicare, to properly bill for services, and laboratories, thereby enabling them to label molecular diagnostic tests.
Reasons to subscribe to U.S. std diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. std diagnostics market databook
-
Our clientele includes a mix of std diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. std diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. std diagnostics market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. std diagnostics market size, by product, 2017-2030 (US$M)
U.S. STD Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
